Helen Tesfaye
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 27, 2025
Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes.Yichen E Fang, Julie M Paik, Janinne Ortega-Montiel
|Oct 17, 2025
GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population-based study.Helen Tesfaye, Julie M Paik, Deborah J Wexler
|Oct 15, 2025
Comparative healthcare resource utilization and costs of empagliflozin and GLP-1 receptor agonists in type 2 diabetes.Phyo Than Htoo, Helen Tesfaye, Sebastian Schneeweiss
|Apr 14, 2025
Trends in Utilization of Glucose- and Weight-Lowering Medications After Tirzepatide Approval in the United States : A Population-Based Cohort Study.John W Ostrominski, Janinne Ortega-Montiel, Helen Tesfaye
|Mar 21, 2024
Effectiveness and safety of empagliflozin: final results from the EMPRISE study.Phyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss
Pageof 1
Frequent Collaborators
5 joint publications
Elisabetta Patorno
2 joint publications
Phyo Than Htoo
2 joint publications
Julie M Paik
1 joint publications
Sebastian Schneeweiss
1 joint publications
Deborah J Wexler
1 joint publications
Robert J Glynn
1 joint publications
John W Ostrominski
1 joint publications
Janinne Ortega-Montiel
1 joint publications
Sara J Cromer
1 joint publications
Yichen E Fang
